Bayer has appointed Simon Rosof as Head of Asia Pacific for its Pharmaceuticals Division, effective 1 July, strengthening its leadership as the region assumes a greater role in driving healthcare innovation and access. 

Based in Singapore, Rosof will also serve as Country Division Head for the ASEAN cluster, overseeing business strategy and performance across Southeast Asia.

Bringing more than two decades of pharmaceutical industry experience, Rosof most recently served as Senior Vice President and Head of Product & Pipeline for Bayer Pharmaceuticals in the United States, where he led commercialization across Oncology, Cardiovascular & Renal, and Women's Healthcare portfolios, covering both marketed products and pipeline assets. 

As a member of Bayer's US Pharmaceuticals and Worldwide Markets leadership teams, he contributed to the company's global pharmaceutical growth strategy.

Sebastian Guth, Chief Operating Officer, Bayer Pharmaceuticals, said: "Simon is a proven leader with a strong track record of delivering growth, developing talent, and building high-performing teams. His global commercial experience, portfolio leadership and deep understanding of healthcare markets make him well suited to lead our Pharmaceuticals business across Asia Pacific and support our teams in bringing innovative medicines to patients."

Over the course of his career, Rosof has held senior leadership positions at Bayer and Bristol Myers Squibb, including serving as General Manager for Bristol Myers Squibb Singapore. His experience spans therapeutic areas including Oncology, Cardiovascular, Renal, Hematology, Virology, Metabolic Diseases, and Women's Health.

Simon Rosof said: "I am honored to take on this role and work alongside our talented teams across Asia Pacific. This region is home to some of the world's most innovative healthcare systems and diverse patient populations. As demand for innovative treatments continues to grow, we have an opportunity to expand patient access, strengthen partnerships across the healthcare ecosystem, and help bring meaningful innovations to more people across the region."

He added that Bayer is well positioned to build on its strong foundation across Asia Pacific by expanding access to innovative medicines, strengthening collaborations across the healthcare community, and addressing some of the region's most pressing healthcare challenges.

Before entering the pharmaceutical industry, Rosof began his career in financial services with Morgan Stanley and Merrill Lynch in New York. He holds an MBA from the Tuck School of Business at Dartmouth and a Bachelor of Arts in Biology from Amherst College.